The Julius L. Chambers Biomedical Biotechnology Research Institute (BBRI) conducts multidisciplinary and interinstitutional research focused on health issues that disproportionately affect minority and underserved populations. With a focus on students, the institute provides research experiences that enhance their access to careers in the biomedical sciences.
BBRI was named for Julius L. Chambers, who received an undergraduate degree in history from NC Central in 1959 and a law degree from UNC-Chapel Hill in 1962, graduating as editor-in-chief of the school's law review and first in his class.
in Grant Funding
Partnerships
Square Feet of Research Space
The Cardiometabolic Program at JRC-BBRI uses collaborative, multi-disciplinary approaches to explore the roles of dietary calcium and stress on hypertension and obesity and the involvement of nuclear hormone receptors.
The JLC-BBRI Toxicology/Carcinogenesis Program explores the causes of cancer and its prevention, using molecular and genetic strategies that define the critical steps in carcinogenesis and explore the interplay between genes and the environment.
Research interests in neuroscience at JRC-BBRI include developmental neurobiology and diseases of the nervous system that disparately afflict minority populations, such as Alzheimer's disease, a neurodegenerative disease that has been suggested to be more prevalent in African Americans and Hispanics.
The Nutrition Research program, located at the North Carolina Research Campus in Kannapolis, NC, uses metabolomic and nutrigenomic approaches to identify and evaluate natural products for disease prevention and treatment.
Since 2016, BBRI has been led by Dr. Deepak Kumar. Click the link below to contact our team.
Interested in working with us? BBRI hires both faculty with appointments in an academic department and research scientists hired to work exclusively in the institute.
Have questions? Reach out to our team, and we'll be glad to provide you with more information about what we do.
BBRI uses private donations to move forward with its research initiatives. Help support us via a contribution today!
